Back

Making inferences with incomplete epidemiological data: a proof-of-concept estimating measles vaccine coverage across Canada

Hadley, L.; Milwid, R.; Hongoh, V.; Wasfi, R.; Kissler, S. M.; Papst, I.

2026-07-17 epidemiology
10.64898/2026.07.16.26358151 medRxiv
Show abstract

Background & aims of study: Current measles outbreaks around the world have highlighted the evolving immunity landscape of some vaccine-preventable diseases (VPDs). In Canada, there have been approximately 1,100 reported measles cases between January and June 2026 alone. This far exceeds the previous average annual case count of <200. This significant outbreak has underscored the need to better understand the present state of population immunity to measles in Canada, an essential input parameter for outbreak response models. Most population immunity in this setting is derived from routine childhood vaccination, but vaccine coverage data is available heterogeneously across the country and is typically collected cross-sectionally to monitor population adherence to immunization schedules rather than to inform population-level susceptibility. This study developed statistical methods to adapt available measles vaccine coverage estimates into more complete estimates of present-day immunity in Canada by age and province/territory (PT). Methods & results: First, a standardized dataset for vaccine coverage by PT was curated from existing publicly-available datasets and reports. A significant number of vaccine coverage estimates were missing by PT, dose, and year. We used Gaussian Process models to impute current coverage with at least one dose of a measles vaccine, to create a complete "modelled dataset" by PT and age. Our modelling framework was also tested against data for England, which was much more complete, to gauge model accuracy. Implications: We developed methodology for estimating vaccine coverage in the absence of detailed population immunity data, to support ongoing measles outbreak modelling response work. While this project focused on measles, we built the associated code/tools such that the methodology can be applied to other vaccine-preventable diseases in future outbreak settings.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Vaccine
203 papers in training set
Top 0.1%
30.7%
2
Epidemics
116 papers in training set
Top 0.1%
12.5%
3
PLOS Global Public Health
344 papers in training set
Top 3%
5.5%
4
PLOS ONE
5266 papers in training set
Top 29%
5.5%
50% of probability mass above
5
BMC Infectious Diseases
133 papers in training set
Top 0.6%
4.3%
6
BMC Public Health
158 papers in training set
Top 2%
3.2%
7
American Journal of Epidemiology
67 papers in training set
Top 0.4%
3.2%
8
BMC Medicine
176 papers in training set
Top 1%
3.2%
9
Vaccine: X
22 papers in training set
Top 0.2%
2.4%
10
PLOS Computational Biology
1863 papers in training set
Top 13%
2.1%
11
Wellcome Open Research
67 papers in training set
Top 0.6%
1.9%
12
Journal of The Royal Society Interface
235 papers in training set
Top 2%
1.9%
13
PLOS Neglected Tropical Diseases
466 papers in training set
Top 5%
1.1%
14
CMAJ Open
12 papers in training set
Top 0.1%
1.1%
15
BMC Medical Research Methodology
47 papers in training set
Top 1%
1.1%
16
Epidemiology and Infection
89 papers in training set
Top 2%
1.0%
17
BMJ Global Health
113 papers in training set
Top 3%
1.0%
18
Royal Society Open Science
214 papers in training set
Top 5%
1.0%
19
BMC Health Services Research
51 papers in training set
Top 2%
0.8%
20
Eurosurveillance
83 papers in training set
Top 1%
0.8%
21
The Lancet Regional Health - Americas
22 papers in training set
Top 0.6%
0.8%
22
Open Forum Infectious Diseases
142 papers in training set
Top 3%
0.6%
23
Vaccines
198 papers in training set
Top 4%
0.6%
24
International Journal of Epidemiology
88 papers in training set
Top 2%
0.6%